Ectopic expression of recipient CD47 inhibits mouse macrophage-mediated immune rejection against human stem cell transplants
Publication in refereed journal


Times Cited
Altmetrics Information
.

Other information
AbstractLike conventional transplants, immunosuppression is required to facilitate survival and function of human embryonic stem cell (hESC) derivatives after implantation into xenogeneic recipients. We have previously reported that T cells alone are sufficient to reject allogeneic murine ESC derivatives; and strategies that inhibit T-cell activation, including coreceptor and costimulation blockade, prevent hESC derivatives from being rejected. This study aimed to investigate, in addition to T cells, whether macrophages contribute to transplant rejection of hESC xenografts with nonobese diabetic (NOD)/SCID mice that lack functional T and B cells but have macrophages. We show that acute rejection against hESC-derived endothelial cells (hESC-ECs) was mediated, to some degree, by infiltrating macrophages that phagocytosed them. Transgenic expression of murine CD47 on cell surface of hESC-ECs mitigates macrophage-mediated phagocytosis and improves their survival after transplantation. Our results highlight that innate immune cells, such as macrophages, can reject hESC derivatives, raising concern against the use of NOD/SCID as transplant recipients for testing in vivo function of hESC-derived tissues. Augmenting CD47 signaling promotes survival and function of hESC derivatives after xenogeneic transplantation.-Leung, C. S., Li, J., Xu, F., Wong, A. S. L., Lui, K. O. Ectopic expression of recipient CD47 inhibits mouse macrophage-mediated immune rejection against human stem cell transplants.
All Author(s) ListLeung CS, Li J, Xu F, Wong ASL, Lui KO
Journal nameFASEB Journal
Year2019
Month1
Volume Number33
Issue Number1
Pages484 - 493
ISSN0892-6638
LanguagesEnglish-United Kingdom
KeywordsESCs,phagocytosis,endothelial cells,immune tolerance,xenotransplantation

Last updated on 2020-25-05 at 00:47